RAPT THERAPEUTICS INC shareholders Q2 2024

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 110 filers reported holding RAPT THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

RAPT THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$8,175,89411.47%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,725,000$5,261,2500.56%
Ghost Tree Capital, LLC 300,000$915,0000.29%
Sio Capital Management, LLC 315,000$960,7500.26%
Euclidean Capital LLC 657,899$2,006,5920.25%
Altium Capital Management LP 200,000$610,0000.25%
ARDSLEY ADVISORY PARTNERS LP 500,000$1,525,0000.22%
Affinity Asset Advisors, LLC 545,000$1,662,2500.19%
Octagon Capital Advisors LP 292,000$890,6000.14%
Ikarian Capital, LLC 2,000$610,0000.11%
Redmile Group, LLC 536,682$1,636,8800.10%
Cormorant Asset Management, LP 496,750$1,515,0880.09%
Alphabet Inc. 540,270$1,647,8240.08%
Ikarian Capital, LLC 154,625$471,6060.08%
PDT Partners, LLC 97,805$298,3050.03%
Affinity Asset Advisors, LLC 75,000$228,7500.03%
XTX Topco Ltd 35,480$108,2140.01%
Hennion & Walsh Asset Management, Inc. 48,525$148,0010.01%
GSA CAPITAL PARTNERS LLP 36,654$1120.01%
Trexquant Investment LP 144,362$440,3040.01%
External links

This page lists RAPT THERAPEUTICS INC's shareholders in Q2 2024. To view RAPT THERAPEUTICS INC's shareholder history, click here.